Cenderitide

Modify Date: 2024-01-22 17:17:22

Cenderitide Structure
Cenderitide structure
Common Name Cenderitide
CAS Number 507289-11-4 Molecular Weight 3745.27
Density N/A Boiling Point N/A
Molecular Formula C158H263N49O50S3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Cenderitide


Cenderitide is a potent agonist of particulate guanylyl cyclase receptor (pGC). Cenderitide is a natriuretic peptide (NP) composed of C-type natriuretic peptide (CNP) fused to the C-terminus of Dendroaspis natriuretic peptide (DNP). Cenderitide activates both pGC-A and pGC-B, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure. Cenderitide can be used for heart failure research[1][2][3].

 Names

Name Cenderitide

 Cenderitide Biological Activity

Description Cenderitide is a potent agonist of particulate guanylyl cyclase receptor (pGC). Cenderitide is a natriuretic peptide (NP) composed of C-type natriuretic peptide (CNP) fused to the C-terminus of Dendroaspis natriuretic peptide (DNP). Cenderitide activates both pGC-A and pGC-B, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure. Cenderitide can be used for heart failure research[1][2][3].
Related Catalog
In Vitro Cenderitide has antiproliferative, anti-fibrotic, and anti-hypertrophic properties[1].
In Vivo In vivo in normal canines, Cenderitide (10, 50, and 100 ng/kg) is a potent cGMP stimulator that has renal enhancing and cardiac unloading effects, with less reduction of blood pressure[1][4].

 Chemical & Physical Properties

Molecular Formula C158H263N49O50S3
Molecular Weight 3745.27